USD365876S - Medicament inhaler - Google Patents

Medicament inhaler Download PDF

Info

Publication number
USD365876S
USD365876S US29/016,154 US1615493F USD365876S US D365876 S USD365876 S US D365876S US 1615493 F US1615493 F US 1615493F US D365876 S USD365876 S US D365876S
Authority
US
United States
Prior art keywords
medicament inhaler
inhaler
view
protective cap
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US29/016,154
Inventor
Brindra P. S. Chawla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Application granted granted Critical
Publication of USD365876S publication Critical patent/USD365876S/en
Assigned to FISONS PLC reassignment FISONS PLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHAWLA, BRINDRA P.S.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Description

FIG. 1 is a perspective view of a medicament inhaler showing my new design;
FIG. 2 is a perspective view thereof, with the protective cap removed;
FIG. 3 is a right side elevational view thereof, the left side elevational view being a mirror image thereto;
FIG. 4 is a front elevational view thereof;
FIG. 5 is a rear elevational view thereof;
FIG. 6 is a top plan view of the inhaler, with the protective cap removed;
FIG. 7 is a bottom plan view of the inhaler, with the protective cap removed and the base shown in open position;
FIG. 8 is a right side elevational view thereof, with the protective cap in place, the left side elevational view being a mirror image thereof;
FIG. 9 is a cross sectional view thereof with the protective cap removed taken along the line 9--9 of FIG. 7;
FIG. 10 is a top plan view of the inhaler, with the protective cap in place; and,
FIG. 11 is a bottom plan view of the inhaler, with the protective cap in place.

Claims (1)

  1. The ornamental design for a medicament inhaler, as shown and described.
US29/016,154 1993-06-16 1993-12-09 Medicament inhaler Expired - Lifetime USD365876S (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2031774 1993-06-16
GB2031774 1993-06-16

Publications (1)

Publication Number Publication Date
USD365876S true USD365876S (en) 1996-01-02

Family

ID=71091776

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/016,154 Expired - Lifetime USD365876S (en) 1993-06-16 1993-12-09 Medicament inhaler

Country Status (1)

Country Link
US (1) USD365876S (en)

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD377215S (en) * 1995-04-13 1997-01-07 Glaxo Group Limited Inhaler
USD433124S (en) * 1998-01-09 2000-10-31 Zeneca Limited Nasal spray
USD433123S (en) * 1998-07-09 2000-10-31 Zeneca Limited Nasal spray
US20090263408A1 (en) * 2003-03-15 2009-10-22 Brintech International Limited Formulation and presentation of medicaments
US20090308390A1 (en) * 2008-06-13 2009-12-17 Smutney Chad C Dry Powder Inhaler and System for Drug Delivery
US20090314292A1 (en) * 2008-06-20 2009-12-24 Dennis Overfield Interactive apparatus and method for real-time profiling of inhalation efforts
US20100197565A1 (en) * 2008-06-13 2010-08-05 Smutney Chad C Dry powder drug delivery system
USD668326S1 (en) * 2009-11-04 2012-10-02 3M Innovative Properties Company Turbo unit cover
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10421729B2 (en) 2013-03-15 2019-09-24 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
USD867575S1 (en) * 2015-11-19 2019-11-19 Emphasys Importadora Exportadora e Distribuidora Inhaler
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10625034B2 (en) 2011-04-01 2020-04-21 Mannkind Corporation Blister package for pharmaceutical cartridges
USD952838S1 (en) * 2019-10-31 2022-05-24 Dxm Co., Ltd. Dual syringe cap
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods

Cited By (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD377215S (en) * 1995-04-13 1997-01-07 Glaxo Group Limited Inhaler
USD433124S (en) * 1998-01-09 2000-10-31 Zeneca Limited Nasal spray
USD433123S (en) * 1998-07-09 2000-10-31 Zeneca Limited Nasal spray
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US20090263408A1 (en) * 2003-03-15 2009-10-22 Brintech International Limited Formulation and presentation of medicaments
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US10130685B2 (en) 2004-08-23 2018-11-20 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9446001B2 (en) 2005-09-14 2016-09-20 Mannkind Corporation Increasing drug affinity for crystalline microparticle surfaces
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US10143655B2 (en) 2005-09-14 2018-12-04 Mannkind Corporation Method of drug formulation
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US8499757B2 (en) 2008-06-13 2013-08-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10751488B2 (en) 2008-06-13 2020-08-25 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8912193B2 (en) 2008-06-13 2014-12-16 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9339615B2 (en) 2008-06-13 2016-05-17 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US20090308392A1 (en) * 2008-06-13 2009-12-17 Smutney Chad C Dry Powder Inhaler and System for Drug Delivery
US9393372B2 (en) 2008-06-13 2016-07-19 Mannkind Corporation Dry powder drug delivery system
US8636001B2 (en) 2008-06-13 2014-01-28 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9446133B2 (en) 2008-06-13 2016-09-20 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9511198B2 (en) 2008-06-13 2016-12-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10342938B2 (en) 2008-06-13 2019-07-09 Mannkind Corporation Dry powder drug delivery system
US10201672B2 (en) 2008-06-13 2019-02-12 Mannkind Corporation Dry powder inhaler and system for drug delivery
US20090308390A1 (en) * 2008-06-13 2009-12-17 Smutney Chad C Dry Powder Inhaler and System for Drug Delivery
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US20100197565A1 (en) * 2008-06-13 2010-08-05 Smutney Chad C Dry powder drug delivery system
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US10675421B2 (en) 2008-06-20 2020-06-09 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US20090314292A1 (en) * 2008-06-20 2009-12-24 Dennis Overfield Interactive apparatus and method for real-time profiling of inhalation efforts
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US10172850B2 (en) 2008-12-29 2019-01-08 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
USD668326S1 (en) * 2009-11-04 2012-10-02 3M Innovative Properties Company Turbo unit cover
US10625034B2 (en) 2011-04-01 2020-04-21 Mannkind Corporation Blister package for pharmaceutical cartridges
US10130709B2 (en) 2011-06-17 2018-11-20 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US10258664B2 (en) 2011-10-24 2019-04-16 Mannkind Corporation Methods and compositions for treating pain
US9610351B2 (en) 2011-10-24 2017-04-04 Mannkind Corporation Methods and compositions for treating pain
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US10421729B2 (en) 2013-03-15 2019-09-24 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
USD867575S1 (en) * 2015-11-19 2019-11-19 Emphasys Importadora Exportadora e Distribuidora Inhaler
USD952838S1 (en) * 2019-10-31 2022-05-24 Dxm Co., Ltd. Dual syringe cap

Similar Documents

Publication Publication Date Title
USD365876S (en) Medicament inhaler
USD355029S (en) Inhaler
USD361160S (en) Face protector with pivoting face shield and stop
USD306701S (en) Tethered dispensing closure
USD326517S (en) Inhalator
USD320930S (en) Package
USD331877S (en) Closure
USD339295S (en) Combined bottle and cap
USD351685S (en) Helmet
USD340546S (en) Helmet
USD364262S (en) Protective cup
USD340545S (en) Helmet
USD333375S (en) Combined cap and back pocket
USD354585S (en) Protective face shield
USD311063S (en) Nursing bottle cap
USD339932S (en) Combined display and storage for gloves
USD351740S (en) Pool chair
USD318329S (en) Sterilization case
USD343904S (en) Centrifuge
USD367760S (en) Container
USD325699S (en) Combined bottle and cap
USD332223S (en) Combined valve and bottle cap
USD353537S (en) Spray container
USD357415S (en) Bottle
USD339983S (en) Vial protective tray